Trials / Completed
CompletedNCT02866877
Effects of Augmented Renal Clearance on Pharmacokinetic and Pharmacodynamic Properties of Levetiracetam in Subarachnoid Hemorrhage
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the pharmacokinetic profile of levetiracetam in critically ill patients who have suffered a subarachnoid hemorrhage. The patients will be evaluated for development of augmented renal clearance and the effects and duration of effects this may have on levetiracetam clearance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pharmacokinetic modeling | Timed blood draws and urine collections to model drug clearance |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2019-06-01
- Completion
- 2021-03-01
- First posted
- 2016-08-15
- Last updated
- 2024-04-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02866877. Inclusion in this directory is not an endorsement.